Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 1380

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 1380
---
, January 1,2026
and January 1, 2027, conditioned upon continuous employment with the Company, and subject to accelerated vesting upon a change in control
of the Company.

    F-26

MY
SIZE, INC. AND ITS SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

U.S.
dollars in thousands (except share data and per share data)

NOTE
14 - STOCK BASED COMPENSATION (Cont.)

The
total stock option compensation expense in the year ended December 31, 2024 amounted to $390 as follows: research and development expenses
amounted to $59, sales and marketing expenses amounted to $46 and general and administrative expenses amounted to $285.

The
total stock option compensation expense in the year ended December 31, 2023 amounted to $371 as follows: research and development expenses
amounted to $71, sales and marketing expenses amounted to $130 and general and administrative expenses amounted to $168.

As
of December 31, 2024, there was a total of $117 unrecognized compensation cost relating to non-vested share-based compensation arrangements.
That cost is expected to be recognized over a weighted-average period of 2.0 years.

Share
option activity during 2024 is as follows:

SCHEDULE
OF SHARES OPTION ACTIVITY 

    2024 

    Number
                                            of options  
    Weighted average exercise price
                                            US$ 
  
    Outstanding
    at January 1 
     13,832  
     8.88 
  
    Granted 
     6,875   
     3.832 
  
    Exercised 
     
    -
     
      -
  
    Expired 
     (6,781)  
     - 
  
    Outstanding
    at year end 
     13,926  
     6.97 
  
    Vested
    at year end 
     7,926   
     8.72  

Share
option activity during 2023 is as follows:

    2023

    Number
                                            of
    options

    Weighted
    average
    Exercise
    price
    US$

    Outstanding
    at January 1

    5,201

    179.84

    Granted

    11,625

    8.72

    Exercised